Aurinia Pharmaceuticals appoints new chief executive

Apr. 12, 2019 2:40 PM ETAurinia Pharmaceuticals Inc. (AUPH)By: Vandana Singh, SA News Editor15 Comments
  • Aurinia Pharmaceuticals (NASDAQ:AUPH -2.9%) appoints Peter Greenleaf as CEO of the company and Director
  • Also, announces the elevation of George Milne, Jr. to Chairman of the Board.
  • Richard Glickman, who previously announced his retirement plans in November 2018, will step down as Chairman & CEO concurrent with Mr. Greenleaf’s appointment on April 29, 2019.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.